---
title: EL-4 Syngeneic Model - TD2 Precision Oncology
description: Explore EL-4, a murine lymphoma cell line used in cancer immunology research. Study immune responses, immunotherapies, and T-cell activation for enhanced anti-tumor immunity.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/el-4.png
---

×

 

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

# EL-4 Syngeneic Model

**Synonyms:** EL4, EL-4 lymphoma cell line

EL-4 is a widely used cancer cell line derived from a murine lymphoma. It serves as a valuable tool in cancer immunology and immunotherapy research. EL-4 cells exhibit characteristics similar to activated T-lymphocytes, making them suitable for studying immune responses, T-cell activation, and anti-tumor immune therapies. Researchers utilize EL-4 to investigate immune checkpoint regulation, tumor infiltrating lymphocytes, and the development of novel immunotherapeutic strategies. This cell line is frequently employed in preclinical models to evaluate the efficacy of immunotherapies, including immune checkpoint inhibitors, CAR-T cell therapies, and vaccines. The EL-4 cell line plays a significant role in advancing our understanding of cancer immunolog

## Model Details

**Cancer Type:** Hematopoietic Cancer  
**Model Name:** EL-4  
**Mouse Strain:** C57BL/6  
**Treatment Data Available:** N/A

## EL-4 Growth Curve

![EL-4 Syngeneic Model](https://td2inc.com/hubfs/Assets/GraphsFigures/el-4.png)

Growth of subcutaneous EL-4 in C57BL/6 mice (n=5)

### Request Additional Syngeneic Model Data

## CONTACT US

## Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.

[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)

[![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en)

Office  
13208 E. Shea Blvd,   
Suite 100   
Scottsdale, AZ 85259

Phone  
(602) 358-8300

Connect with us

- <https://www.linkedin.com/company/translational-drug-development/>
- <https://twitter.com/TD2_Oncology>

![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png)

© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)